Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Update

$Gain Therapeutics(GANX.US)$ Gain Therapeutics Announces the Initiation of the Multiple Ascending Dose (MAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-targeting Small Molecule Therapy for GBA1 Parkinson's Disease
7 MINUTES AGO, 2:00 PM EST
VIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
Translate
Report
1511 Views
Comment
Sign in to post a comment
1752Followers
28Following
20KVisitors
Follow